Innovation Management
Innovation Management – A Biotech Approach to Technology Transfer
The Innovation Management (IM) team at DKFZ propels groundbreaking cancer research into practical, impactful applications, actively supporting researchers and industry partners in advancing discoveries that benefit patients and society. Across five specialized groups (see below) IM secures and develops intellectual property, builds alliances, and drives entrepreneurial ventures that bring pioneering therapies to the forefront. Under the strategic leadership of Chief Innovation Officer Rainer Wessel, IM orchestrates the transition from concept to cure, reinforcing DKFZ's role as a driving force for innovation, entrepreneurship, and progress in the battle against cancer.
Team Innovation Management
"In the field of innovation, our mission is to deploy every resource strategically and press forward with precision—because every breakthrough is a step closer to victory in the fight against cancer."
Led by Dirk Kuck this group expertly navigates the lifecycle of DKFZ's research projects, from initial validation to product development. Their focus on strategy and efficient project execution ensures that promising research moves seamlessly through development stages, bringing innovative cancer therapies closer to market.
Search Technologies
Explore innovative technologies and connect with unique licensing and partnership opportunities to drive your business forward. Powered by IN-PART.
General Terms and Conditions for the execution of research and development orders in the Deutsches Krebsforschungszentrum (German Cancer Research Center) Heidelberg,
Status: January 2019 Terms and Conditions (English). Status: April 2019 Terms and Conditions, AGBs (Deutsch).